[Exhibition Highlights] New Line Bio-Tech Featured at the 21st AAAP Animal Science Congress, Garnering Global Client Acclaim
— Sustainable Animal Husbandry · Official Sponsor Presentation | Booth: 09
From October 28 to 31, 2026, the 21st Animal Science Congress of the Asian-Australasian Association of Animal Production Societies (AAAP 2026) was held at the National Convention Center (NCC) in Hanoi, Vietnam. Centered around the theme of “Sustainable Animal Husbandry”, the congress convened over a thousand eminent scientists, scholars, and industry executives from more than 40 countries and territories. As an official sponsor and global pioneer in industrial bacteriophage solutions, New Line Bio-Tech presented its latest breakthroughs in precision biocontrol and green farming technologies, becoming an undisputed spotlight of the congress!
01 · Spearheading Sustainable Farming: Precision Biocontrol in High Demand
Amid the worldwide transition toward antibiotic reduction and sustainable livestock production, bacteriophage technology has emerged as an indispensable strategic modality. Characterized by precision bactericidal targeting, zero chemical residues, environmental safety, and absence of antimicrobial resistance (AMR) induction, phages provide an eco-friendly defense system against stubborn bacterial infections.
At this premier international summit, New Line Bio-Tech exhibited its comprehensive technological ecosystem, encompassing high-throughput phage screening platforms, industrial-scale submerged fermentation facilities, synergistic multi-phage formulations, and field-tested application protocols. These solutions directly resolve critical industry challenges, including multi-drug resistant pathogens and post-antibiotic dysbiosis across poultry, swine, and aquaculture operations.
High attendee engagement at New Line Bio-Tech Booth 09 during AAAP 2026
02 · In-Depth Technical Exchanges and International Strategic Collaborations
Throughout the four-day event, Booth 09 welcomed delegations representing top agricultural conglomerates, feed manufacturers, and veterinary distributors from Southeast Asia, Europe, the Americas, and the Middle East. Discussions focused on phage lysis kinetics, clinical field efficacy data, environmental tolerance parameters, regional strain compatibility, and international distribution partnerships. Upon reviewing New Line Bio-Tech's strategic asset base—featuring over 60,000 characterized bacterial strains and six dedicated submerged fermentation lines—several major overseas clients initiated immediate procurement discussions and strategic memorandums.
International partners and delegates commending New Line Bio-Tech's biocontrol portfolio
03 · Expert Scientific Consultation Delivering Tailored Biosecurity Frameworks
Dr. Linna Zhu personally led the scientific advisory desk at the booth, delivering personalized consultations to visiting delegations. Addressing common regional pathogens such as Salmonella, Escherichia coli, Clostridium perfringens, and aquatic Vibrio species prevalent in tropical environments, Dr. Zhu elucidated phage receptor-binding mechanisms, formulation strategies against antigenic shifts, and integrated farm biosecurity protocols.
Dr. Linna Zhu addressing specific clinical questions for international farming enterprises
The rigorous, data-backed technical consultation received unanimous praise from international delegates, affirming New Line Bio-Tech's role as a trusted global partner in sustainable livestock and aquaculture health.
Connect with Us
Shandong New-Line Biotechnology Co., Ltd.
Dedicated to the industrialization of bacteriophage biocontrol solutions in agriculture and animal health. Equipped with 6 fermentation production lines and a repository of over 60,000 pathogenic bacterial strains.
Hotline: +86-536-2201616
Official Portals: phages.cn / phages.biz